FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/07/2026
Back to search
Official data from USPTO
A3P BIOMEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
A3P BIOMEDICAL
ST13
US500000079397842Class
5, 9, 10, 42, 44
Filing
79397842
Registration
7979666
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
05/08/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
03/21/2024
Registration date
10/14/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/14/2025
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
SINGER, MELANIE ALYSSA
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
A3P Biomedical AB
Representatives
Ronald E. Shapiro Shapiro and Silverstein PLLC
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and veterinary preparations and articlesdiagnostic test reagents for medical purposes for prostate cancer testing; diagnostic preparations and material preparations in the nature of pharmaceuticals for medical purposes being for treatment of cancer; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical use in the nature of reagents for medical purposes; diagnostic test materials reagents for medical purposes for prostate cancer testing; diagnostic preparations for medical purposes; diagnostic agents for medical use
Class 9
Downloadable software for calculating the risk of prostate cancer; downloadable computer programs for calculating the risk of prostate cancer; downloadable computer software for prostate cancer tests; downloadable application software for calculating the risk of prostate cancer; scientific research and laboratory apparatus for measuring proteins and genetics; educational apparatus and simulatorsmedical diagnostics training simulators in the field of prostate cancer; scientific laboratory research instruments for the detection of proteins and genetics for medical research and training purposes; and parts and fittings for all the aforesaid goods included in this classcomputer peripherals and parts thereof
Class 10
Medical and veterinary apparatus and instrumentsprotein and genetics measurements instruments for diagnostic and treatment purposes; medical diagnosticexaminationmonitoring equipment for prostate cancer for medical treatment purposes; testing apparatus for medical purposes for prostate cancer detection; medical test instruments for diagnosis and treatment of prostate cancer; testing probes for medical diagnostic purposes; testing instruments for medical diagnostic purposes being for use in diagnosing prostate cancer; tools for medical diagnosis of prostate cancertools for calculation of prostate cancer risk; apparatus for carrying-out diagnostic tests for medical purposesultrasound diagnostic apparatus for diagnosing prostate cancer
Class 42
IT integration services; computer software developmentprogramming and implementation for others; website hosting services; software as a service featuring computer software for calculating a prostate cancer risk score; rental of computer software for calculating cancer risk; providing temporary use of online non¬-downloadable computer software for calculating a prostate cancer risk score; application service providerfeaturing computer software programs for calculating a prostate cancer risk score; scientific and technology servicesscientific researchanalysistestingmedical and pharmacological research services in the field of prostate cancer; conducting research clinical trials for others in the field of prostate cancer; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical research laboratory services in the field of prostate cancer; and adviceconsultancy and information relating to the aforesaidincluded in this classmedical research laboratory services
Class 44
Human healthcare servicesdisease management programs; medical services; medical testing services; medical diagnostic services; medical diagnostic testing services for prostate cancer; providing online information services relating to medical and diagnostic testsnamely information regarding prostate cancer tests for diagnosis and treatment purposes; prostate cancer screening services; prostate cancer medical testing services; prostate cancer diagnostic medical testing services; medical testing services relating to prostate cancer; taking of blood for medical testing in the nature of phlebotomy services; services for the medical testing of blood; performing diagnosis of diseases; medical testing for diagnostic or treatment purposes; medical diagnostic servicesblood sampling and analysis; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease in the nature of medical diagnostic services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing medical information relating to medical results and diagnostic testsprostate cancer tests; providing medical diagnostic information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory analysis services for the analysis of samples and blood samples taken from patients for diagnostic and treatment purposes; rental of medical equipment for human healthcare; and adviceconsultancyinformation relating to the aforesaidincluded in this classmedical diagnostic consulting and information services
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/21/2026
FIMP
FINAL DISPOSITION PROCESSED
04/21/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/14/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/05/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/19/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/26/2025
PUBO
PUBLISHED FOR OPPOSITION
08/26/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/20/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/13/2025
GNFR
FINAL REFUSAL E-MAILED
05/13/2025
CNFR
FINAL REFUSAL WRITTEN
05/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/28/2025
DOCK
ASSIGNED TO EXAMINER
11/06/2024
RFNT
REFUSAL PROCESSED BY IB
10/26/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/04/2024
RFRR
REFUSAL PROCESSED BY MPU
10/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/30/2024
CNRT
NON-FINAL ACTION WRITTEN
09/29/2024
DOCK
ASSIGNED TO EXAMINER
09/29/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/20/2024
Continuous trademark protection
Get notified about every new filing that threatens A3P BIOMEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.